It is a fmcg private limited company based in New Delhi, Delhi, India, established in 2009.
2009 | New Delhi, Delhi, India | ActiveSpan Generics Private Limited, a active private limited company, was established on 26 August 2009 in New Delhi, Delhi, India. Engaging in personal care & skincare products within the fmcg sector, it holds CIN: U24100DL2009PTC193604. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Vinod Suri (Director), Sandeep Kumar Ajmani (Director), Deepti Ajmani (Director). Past directors included Kulbhushan Kumar Suri, Sandeep Kumar Ajmani. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 110 Dlf Tower 15 Shivaji Marg, New Delhi, Delhi, 110015.
U24100DL2009PTC193604
193604
26 August 2009
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Span Generics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vinod Suri | Director | 20 Feb 2022 | Current |
| Sandeep Kumar Ajmani | Director | 25 Jan 2023 | Current |
| Deepti Ajmani | Director | 26 Aug 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 25 Feb 2022 | Past |
| Pramod Abcsdd | Director | 03 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Span Generics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 51826.16% increase. The company also saw a substantial improvement in profitability, with a 406280.7% increase in profit. The company's net worth Soared by an impressive increase of 1293.57%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Span Generics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Span Generics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Span Generics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Span Generics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Span Generics Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
Span Generics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was recorded as a recent event.
Sandeep Kumar Ajmani was appointed as a Director was appointed as a Director on 25 Jan 2023 & has been associated with this company since 2 years 10 months . was recorded as a recent event.
Progress on Vinod Suri was appointed as a Director was appointed as a Director on 20 Feb 2022 & has been associated with this company since 3 years 9 months . was documented.
Deepti Ajmani was appointed as a Director was appointed as a Director on 26 Aug 2009 & has been associated with this company since 16 years 3 months . was recorded as a recent event.
Progress on Span Generics Private Limited was registered on 26 Aug 2009 with Roc Delhi & aged 16 years 3 months as per MCA records. was documented.
The CIN of Span Generics Private Limited is U24100DL2009PTC193604.
Span Generics Private Limited is headquartered at 110 Dlf Tower 15 Shivaji Marg, New Delhi, Delhi, 110015.
Span Generics Private Limited was incorporated on 26 August 2009.
The current directors of Span Generics Private Limited are
The primary industry of Span Generics Private Limited is Fmcg.
Span Generics Private Limited is unlisted.
The authorized capital of Span Generics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Span Generics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX